Log in Register
Menu

Anti-c-Met [17]

Invented by Dr Julin Wong at A*STAR, David Lane at Karolinska Institutet

Info

Catalogue Number 152665
Applications FACS IF IP WB
Antigen/Gene or Protein Targets c-Met, cMet
Reactivity Human
Relevance c-Met is a tyrosine receptor kinase which is activated by its ligand, the hepatocyte growth factor. Activation of c-Met leads to a wide spectrum of biological activities such as motility, angiogenesis, morphogenesis, cell survival and cell regeneration. c-Met is abnormally activated in many tumour types. Aberrant c-Met activation was found to induce tumour development, tumour cell migration and invasion, and the worst and final step in cancer progression, metastasis.
Host Mouse
Immunogen Bacterially expressed human c-Met alpha chain
Subclass IgG1 kappa
Positive Control SNU-5, U-87MG and MKN45 cells (negative control: T47D cells)
Myeloma Used Sp2/0-Ag14
Notes Epitope: LVVDTYYDDQ / FRDS - two different epitopes. Note that clone 13 is best for FACS
Research Area Cancer, Cell Signaling & Signal Transduction, Epigenetics & Nuclear Signalling

References: 1 entry

Wong et al. 2013. Oncotarget. 4(7):1019-36. PMID: 23859937.


Add a reference

References: 1 entry

Wong et al. 2013. Oncotarget. 4(7):1019-36. PMID: 23859937.


Add a reference

References: 1 entry

Wong et al. 2013. Oncotarget. 4(7):1019-36. PMID: 23859937.


Add a reference


This reagent does not have any reviews at the moment.